Targeting immunosuppression for cancer therapy
نویسندگان
چکیده
منابع مشابه
Targeting STATs for cancer therapy
We are in the midst of an exciting transition in the treatment of cancers, from the empirically developed non-specifically cytotoxic drugs to the era of rationally derived molecularly targeted therapies. Over the past 15 years, our understanding of the mutations that drive cancer pathogenesis has grown enormously, which has rapidly led to the development of drugs to target the associated gene p...
متن کاملTargeting Mnks for Cancer Therapy
Deregulation of protein synthesis is a common event in human cancer and a key player in translational control is eIF4E. Elevated expression levels of eIF4E promote cancer development and progression. Recent findings suggest that eIF4E activity is a key determinant of the PI3K/Akt/mTOR and Ras/Raf/MEK/ERK mediated tumorigenic activity and targeting eIF4E should have a major impact on these pathw...
متن کاملTargeting Aneuploidy for Cancer Therapy
Tumor cells frequently display an abnormal number of chromosomes, a phenomenon known as aneuploidy. Tang et al. (2011) now show that aneuploid cells are particularly sensitive to compounds that induce proteotoxic and energy stress. Could this vulnerability lead to new cancer therapies?
متن کاملTargeting the Jak/STAT pathway for immunosuppression.
W hile many effective immunosuppressive drugs exist and are in wide use, most target ubiquitously expressed molecules. Examples include steroids, ciclosporin A, tacrolimus, mycophenolate mofetil, and sirolimus. Consequently, these drugs have adverse effects unrelated to their immunosuppressive actions, and much effort has been directed towards identifying molecular targets with expression restr...
متن کاملTargeting MicroRNAs for Personalized Cancer Therapy
and CD24 –/lo have aberrant expression of miRNAs and much greater self-renewal activity, proliferation and tumor initiation than other cancer cells. The high expression of miR-21, miR-181a and miR-181b has been observed in breast CSCs; however, these cells express very low levels of let-7, miR-34, miR-200, miR-29, miR-30a and miR-93. Similar to breast CSCs, prostate CSCs express a very low leve...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Investigation
سال: 2013
ISSN: 0021-9738
DOI: 10.1172/jci69999